Participants began with an average HbA1c level of 8.1%. After three months, people who used Omnipod 5 improved HbA1c by an ...

Continuous glucose monitors (CGMs) are monitoring devices people with diabetes use. They apply them directly to the skin and ...

We are thrilled to announce our collaboration with Abbott, integrating its world-leading FreeStyle Libre technology 2 as our first CGM partner, marking a significant milestone as we bring our ...

Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's ...

Sequel Med Tech has announced that Abbott’s FreeStyle Libre 3 Plus sensor will be the first continuous glucose monitoring device to work with its twiist Automated Insulin Delivery (AID) System powered ...

Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...

Sequel Med Tech announced today that it integrated its twiist automated insulin delivery (AID) with the Abbott FreeStyle Libre 3 Plus sensor.

Abbott’s Freestyle Libre, approved by the FDA in 2017, is one such device. A diabetes diagnosis can come with many difficult lifestyle changes, including frequent blood sugar checks. To check ...

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Australia, launching soon in Belgium, Canada ...

The following is a summary of “Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in ...